Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine Add-on to Valproate for Bipolar II Disorder
NCT01188148Phase 3Completed
- Sponsor
- National Cheng Kung University Hospital
- Start
- Aug 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of memantine in Bipolar II disorder (BP-II) (4 arms), sponsored by National Cheng Kung University Hospital. Primary endpoints: Young's Mania Rating Scale at 12 weeks and Hamilton Depression Rating Scale at 12 weeks. Started Aug 2009; status: completed.
02
Drugs
memantine
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT01188148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01188148.